Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Core Scientific (CORZ) Change in Cash (2021 - 2025)

Historic Change in Cash for Core Scientific (CORZ) over the last 5 years, with Q3 2025 value amounting to -$127.9 million.

  • Core Scientific's Change in Cash fell 18162.38% to -$127.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $199.6 million, marking a year-over-year increase of 515.22%. This contributed to the annual value of $767.3 million for FY2024, which is 429218.62% up from last year.
  • According to the latest figures from Q3 2025, Core Scientific's Change in Cash is -$127.9 million, which was down 18162.38% from -$117.4 million recorded in Q2 2025.
  • Core Scientific's Change in Cash's 5-year high stood at $583.2 million during Q4 2024, with a 5-year trough of -$138.3 million in Q1 2025.
  • Moreover, its 5-year median value for Change in Cash was $7.5 million (2023), whereas its average is $23.4 million.
  • Its Change in Cash has fluctuated over the past 5 years, first soared by 1001408.26% in 2024, then tumbled by 58359.44% in 2025.
  • Over the past 5 years, Core Scientific's Change in Cash (Quarter) stood at -$28.3 million in 2021, then skyrocketed by 151.52% to $14.6 million in 2022, then tumbled by 60.5% to $5.8 million in 2023, then soared by 10014.08% to $583.2 million in 2024, then tumbled by 121.93% to -$127.9 million in 2025.
  • Its Change in Cash was -$127.9 million in Q3 2025, compared to -$117.4 million in Q2 2025 and -$138.3 million in Q1 2025.